C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study (Q46406619)

21 December 2017

title

C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study (English)

1 reference

21 December 2017

main subject

cardiovascular disease

1 reference

1 reference

1 reference

8

1 reference

21 December 2017

Tine W Hansen

object named as

Tine W Hansen

2

0 references

Christian Torp-Pedersen

6

object named as

Christian Torp-Pedersen

1 reference

21 December 2017

Jørgen Jeppesen

1

1 reference

21 December 2017

Michael H Olsen

3

1 reference

21 December 2017

Susanne Rasmussen

4

1 reference

21 December 2017

Hans Ibsen

5

1 reference

21 December 2017

Per R Hildebrandt

7

1 reference

21 December 2017

publication date

1 October 2008

1 reference

21 December 2017

European Journal of Cardiovascular Prevention and Rehabilitation

published in

1 reference

21 December 2017

volume

15

1 reference

21 December 2017

issue

5

1 reference

21 December 2017

page(s)

594-598

1 reference

21 December 2017

C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus

cites work

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328308BB8B

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328308BB8B

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328308BB8B

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328308BB8B

Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328308BB8B

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328308BB8B

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328308BB8B

C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328308BB8B

High-sensitivity C-reactive protein in every chart? The use of biomarkers in individual patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328308BB8B

Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328308BB8B

Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328308BB8B

The effect of six polymorphisms in the Apolipoprotein B gene on parameters of lipid metabolism in a Danish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328308BB8B

Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60-year-old Danes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328308BB8B

High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328308BB8B

Relation between insulin and aortic stiffness: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328308BB8B

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328308BB8B

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328308BB8B

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328308BB8B

The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328308BB8B

Insulin sensitivity, proinsulin and insulin as predictors of coronary heart disease. A population-based 10-year, follow-up study in 70-year old men using the euglycaemic insulin clamp

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328308BB8B

Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328308BB8B

10.1097/HJR.0B013E328308BB8B

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

18753952

1 reference

21 December 2017